Molecular nevogenesis

Dermatology Research and Practice

Volumn 2011, Issue , 2011, Pages

  Ross, Andrew L ^a   Sanchez, Margaret I ^a   Grichnik, James M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861481682     PISSN: None     EISSN: 16876113     Source Type: Journal    
DOI: 10.1155/2011/463184     Document Type: Review

References (58)

1. Robinson W. A., Lemon M., Elefanty A., Harrison-Smith M., Markham N., Norris D., Human acquired naevi are clonal. Melanoma Research 1998 8 6 499 503 2-s2.0-0032444269 (Pubitemid 29046500)
2. Hui P., Perkins A. S., Glusac E. J., Assessment of clonality in melanocytic nevi. Journal of Cutaneous Pathology 2001 28 3 140 144 2-s2.0-0035150310 10.1034/j.1600-0560.2001.028003140.x (Pubitemid 32112999)
3. Carr J., Mackie R. M., Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. British Journal of Dermatology 1994 131 1 72 77 10.1111/j.1365-2133.1994.tb08460.x (Pubitemid 24234291)
4. Jafari M., Papp T., Kirchner S., Diener U., Henschler D., Burg G., Schiffmann D., Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma. Journal of Cancer Research and Clinical Oncology 1995 121 1 23 30 2-s2.0-0028891865
5. Papp T., Pemsel H., Zimmermann R., Bastrop R., Weiss D. G., Schiffmann D., Mutational analysis of the N-ras, p53, p16(INK4a), CDK4, and MC1R genes in human congenital melanocytic naevi. Journal of Medical Genetics 1999 36 8 610 614 2-s2.0-0032767677 (Pubitemid 29368901)
6. Pollock P. M., Harper U. L., Hansen K. S., Yudt L. M., Stark M., Robbins C. M., Moses T. Y., Hostetter G., Wagner U., Kakareka J., Salem G., Pohida T., Heenan P., Duray P., Kallioniemi O., Hayward N. K., Trent J. M., Meltzer P. S., High frequency of BRAF mutations in nevi. Nature Genetics 2003 33 1 19 20 2-s2.0-0037228055 10.1038/ng1054 (Pubitemid 36068675)
7. Yazdi A. S., Palmedo G., Flaig M. J., Puchta U., Reckwerth A., Rütten A., Mentzel T., Hügel H., Hantschke M., Schmid-Wendtner M. H., Kutzner H., Sander C. A., Mutations of the BRAF gene in benign and malignant melanocytic lesions. Journal of Investigative Dermatology 2003 121 5 1160 1162 2-s2.0-10744222648 10.1046/j.1523-1747.2003.12559.x (Pubitemid 37430987)
8. Papp T., Schipper H., Kumar K., Schiffmann D., Zimmermann R., Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi. Melanoma Research 2005 15 5 401 407 2-s2.0-27644559365 10.1097/00008390- 200510000-00008 (Pubitemid 41558950)
9. De Raeve L. E., Claes A., Ruiter D. J., Van Muijen G. N. P., Roseeuw D., Van Kempen L. C. L. T., Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage. British Journal of Dermatology 2006 154 3 485 492 2-s2.0-33644918573 10.1111/j.1365-2133.2005.07055.x (Pubitemid 43382657)
10. Ichii-Nakato N., Takata M., Takayanagi S., Takashima S., Lin J., Murata H., Fujimoto A., Hatta N., Saida T., High frequency of BRAF mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. Journal of Investigative Dermatology 2006 126 9 2111 2118 2-s2.0-33746819361 10.1038/sj.jid.5700366
11. Bauer J., Curtin J. A., Pinkel D., Bastian B. C., bastian@cc.ucsf.edu Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. Journal of Investigative Dermatology 2007 127 1 179 182 10.1038/sj.jid.5700490 (Pubitemid 46005676)
12. Wu J., Rosenbaum E., Begum S., Westra W. H., Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis. American Journal of Dermatopathology 2007 29 6 534 537 2-s2.0-36348936129 10.1097/DAD.0b013e3181584950 (Pubitemid 350158863)
13. Dessars B., De Raeve L. E., Morandini R., Lefort A., El Housni H., Ghanem G. E., Van den Eynde B. J., Ma W., Roseeuw D., Vassart G., Libert F., Heimann P., Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis. The Journal of Investigative Dermatology 2009 129 1 139 147 10.1038/jid.2008.203
14. Takata M., Saida T., Genetic alterations in melanocytic tumors. Journal of Dermatological Science 2006 43 1 1 10 2-s2.0-33744535687 10.1016/j.jdermsci. 2006.05.002 (Pubitemid 43817500)
15. Demunter A., Stas M., Degreef H., De Wolf-Peeters C., Van den Oord J. J., Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. Journal of Investigative Dermatology 2001 117 6 1483 1489 2-s2.0-0035670803 10.1046/j.0022-202x.2001.01601.x (Pubitemid 34032777)
16. Kumar R., Angelini S., Hemminki K., Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9. Oncogene 2003 22 58 9217 9224 2-s2.0-1442269853 10.1038/sj.onc.1206909 (Pubitemid 38122033)
17. Van Dijk M. C. R. E., Bernsen M. R., Ruiter D. J., Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. American Journal of Surgical Pathology 2005 29 9 1145 1151 2-s2.0-24144435358 10.1097/01.pas.0000157749.18591.9e (Pubitemid 41232985)
18. Bastian B. C., Wesselmann U., Pinkel D., LeBoit P. E., Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. Journal of Investigative Dermatology 1999 113 6 1065 1069 2-s2.0-0033396288 10.1046/j.1523-1747.1999.00787.x (Pubitemid 30013354)
19. Bastian B. C., LeBoit P. E., Pinkel D., Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. American Journal of Pathology 2000 157 3 967 972 2-s2.0-0034491067 (Pubitemid 32109388)
20. Palmedo G., Hantschke M., Rütten A., Mentzel T., Hügel H., Flaig M. J., Yazdi A. S., Sander C. A., Kutzner H., The T1796A mutation of the BRAF gene is absent in Spitz nevi. Journal of Cutaneous Pathology 2004 31 3 266 270 2-s2.0-1242315442 10.1111/j.0303-6987.2003.00179.x (Pubitemid 38230570)
21. Mihic-Probst D., Perren A., Schmid S., Saremaslani P., Komminoth P., Heitz P. U., Absence of BRAF gene mutations differentiates Spitz nevi from malignant melanoma. Anticancer Research 2004 24 4 2415 2418 2-s2.0-4444384601 (Pubitemid 39166325)
22. Saldanha G., gss4@le.ac.uk Purnell D., Fletcher A., Potter L., Gillies A., Pringle J. H., High BRAF mutation frequency does not characterize all melanocytic tumor types. International Journal of Cancer 2004 111 5 705 710 10.1002/ijc.20325 (Pubitemid 39062892)
23. Gill M., Renwick N., Silvers D. N., Çelebi J. T., Lack of BRAF mutations in Spitz nevi. Journal of Investigative Dermatology 2004 122 5 1325 1326 2-s2.0-2442453280 10.1111/j.0022-202X.2004.22530.x (Pubitemid 38651110)
24. Turner D. J., Zirvi M. A., Barany F., Elenitsas R., Seykora J., Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction. Journal of Cutaneous Pathology 2005 32 5 334 339 2-s2.0-17444424227 10.1111/j.0303-6987.2005.00338.x (Pubitemid 40547791)
25. Fullen D. R., Poynter J. N., Lowe L., Su L. D., Elder J. T., Nair R. P., Johnson T. M., Gruber S. B., BRAF and NRAS mutations in spitzoid melanocytic lesions. Modern Pathology 2006 19 10 1324 1332 2-s2.0-33748875133 10.1038/modpathol.3800653 (Pubitemid 44423079)
26. La Porta C. A. M., Cardano R., Facchetti F., Presicce P., Rao S., Privitera E., Clemente C., Mihm M. C., BRAF V599E mutation occurs in Spitz and Reed naevi. Journal of the European Academy of Dermatology and Venereology 2006 20 9 1164 1165 2-s2.0-33748889772 10.1111/j.1468-3083.2006.01665.x (Pubitemid 44425997)
27. Takata M., Lin J., Takayanagi S., Suzuki T., Ansai S., Kimura T., Cerroni L., Saida T., Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion. British Journal of Dermatology 2007 156 6 1287 1294 2-s2.0-34447095064 10.1111/j.1365-2133.2007.07924.x (Pubitemid 47029852)
28. Da Forno P. D., Pringle J. H., Fletcher A., Bamford M., Su L., Potter L., Saldanha G., BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance. The British journal of dermatology 2009 161 2 364 372 2-s2.0-73349116574
29. Emley A., Yang S., Wajapeyee N., Green M. R., Mahalingam M., Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations. Journal of Cutaneous Pathology 2010 37 3 344 349 2-s2.0-75749147661 10.1111/j.1600-0560.2009.01433.x
30. Dumaz N., Hayward R., Martin J., Ogilvie L., Hedley D., Curtin J. A., Bastian B. C., Springer C., Marais R., richard.marais@icr.ac.uk In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. Cancer Research 2006 66 19 9483 9491 10.1158/0008-5472.CAN-05-4227 (Pubitemid 44623646)
31. Wojnowski L., Stancato L. F., Larner A. C., Rapp U. R., Zimmer A., Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis. Mechanisms of Development 2000 91 1-2 97 104 2-s2.0-0033997943 10.1016/S0925-4773(99)00276-2 (Pubitemid 30125909)
32. Smalley K. S. M., Xiao M., Villanueva J., Nguyen T. K., Flaherty K. T., Letrero R., Van Belle P., Elder D. E., Nathanson K. L., Herlyn M., CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations. Oncogene 2009 28 1 85 94 2-s2.0-58149328950 10.1038/onc.2008.362
33. Dong J., Phelps R. G., Qiao R., Yao S., Benard O., Ronai Z., Aaronson S. A., BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Research 2003 63 14 3883 3885 2-s2.0-0042743826 (Pubitemid 36917898)
34. Poynter J. N., Elder J. T., Fullen D. R., Nair R. P., Soengas M. S., Johnson T. M., Redman B., Thomas N. E., Gruber S. B., BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Research 2006 16 4 267 273 2-s2.0-33746263912 10.1097/01.cmr.0000222600.73179.f3 (Pubitemid 44090170)
35. Uribe P., Andrade L., Gonzalez S., Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi. Journal of Investigative Dermatology 2006 126 1 161 166 2-s2.0-33644775655 10.1038/sj.jid.5700011 (Pubitemid 43336108)
36. Bloethner S., Snellman E., Bermejo J. L., Hiripi E., Gast A., Thirumaran R. K., Wellenreuther R., Hemminki K., Kumar R., Differential gene expression in melanocytic nevi with the V600E BRAF mutation. Genes Chromosomes and Cancer 2007 46 11 1019 1027 2-s2.0-34848920124 10.1002/gcc.20488 (Pubitemid 47502841)
37. Venesio T., Chiorino G., Balsamo A., Zaccagna A., Petti C., Scatolini M., Pisacane A., Sarotto I., Picciotto F., Risio M., In melanocytic lesions the fraction of BRAF alleles is associated with sun exposure but unrelated to ERK phosphorylation. Modern Pathology 2008 21 6 716 726 2-s2.0-44349127222 10.1038/modpathol.2008.41 (Pubitemid 351744837)
38. Hussein M. R. A. E., Wood G. S., Molecular aspects of melanocytic dysplastic nevi. Journal of Molecular Diagnostics 2002 4 2 71 80 2-s2.0-0036113905 (Pubitemid 34555500)
39. Blokx W. A. M., Van Dijk M. C. R. F., Ruiter D. J., Molecular cytogenetics of cutaneous melanocytic lesions-diagnostic, prognostic and therapeutic aspects. Histopathology 2010 56 1 121 132 2-s2.0-73449101483 10.1111/j.1365-2559.2009.03452.x
40. Van Raamsdonk C. D., Bezrookove V., Green G., Bauer J., Gaugler L., O'Brien J. M., Simpson E. M., Barsh G. S., Bastian B. C., Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009 457 7229 599 602 2-s2.0-59049107421 10.1038/nature07586
41. Yan J., Roy S., Apolloni A., Lane A., Hancock J. F., Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. Journal of Biological Chemistry 1998 273 37 24052 24056 2-s2.0-0032508517 10.1074/jbc.273.37.24052 (Pubitemid 28435747)
42. Davies H., Bignell G. R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M. J., Bottomley W., Davis N., Dicks ED., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B. A., Cooper C., Shipley J., Hargrave D., Pritchard-Jones K., Maitland N., Chenevix-Trench G., Riggins G. J., Bigner D. D., Palmleri G., Cossu A., Flanagan A., Nicholson A., Ho J. W. C., Leung S. Y., Yuen S. T., Weber B. L., Seigler H. F., Darrow T. L., Paterson H., Marais R., Marshall C. J., Wooster R., Stratton M. R., Futreal P. A., Mutations of the BRAF gene in human cancer. Nature 2002 417 6892 949 954 2-s2.0-18444374405 10.1038/nature00766 (Pubitemid 34716871)
43. Uribe P., Wistuba I. I., González S., A frequent event in benign, atypical, and malignant melanocytic lesions of the skin. American Journal of Dermatopathology 2003 25 5 365 370 2-s2.0-0141565499 10.1097/00000372-200310000- 00001 (Pubitemid 37169463)
44. Maldonado J. L., Fridlyand J., Patel H., Jain A. N., Busam K., Kageshita T., Ono T., Albertson D. G., Pinkel D., Bastian B. C., Determinants of BRAF mutations in primary melanomas. Journal of the National Cancer Institute 2003 95 24 1878 1890 2-s2.0-0346728596
45. Thomas N. E., Edmiston S. N., Alexander A., Millikan R. C., Groben P. A., Hao H., Tolbert D., Berwick M., Busam K., Begg C. B., Mattingly D., Ollila D. W., Chiu K. T., Hummer A., Lee-Taylor J., Conway K., Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiology Biomarkers and Prevention 2007 16 5 991 997 2-s2.0-34250307902 10.1158/1055-9965.EPI-06-1038 (Pubitemid 46910102)
46. Landi M. T., Bauer J., Pfeiffer R. M., Elder D. E., Hulley B., Minghetti P., Calista D., Kanetsky P. A., Pinkel D., Bastian B. C., MC1R germline variants confer risk for BRAF-mutant melanoma. Science 2006 313 5786 521 522 2-s2.0-33746589029 10.1126/science.1127515 (Pubitemid 44148456)
47. García-Borrón J. C., Sánchez-Laorden B. L., Jiménez-Cervantes C., Melanocortin-1 receptor structure and functional regulation. Pigment Cell Research 2005 18 6 393 410 2-s2.0-28044450150 10.1111/j.1600-0749.2005.00278.x (Pubitemid 41691455)
48. Más J. S., Gerritsen I., Hahmann C., Jiménez-Cervantes C., García-Borrón J. C., Rate limiting factors in melanocortin 1 receptor signalling through the cAMP pathway. Pigment Cell Research 2003 16 5 540 547 2-s2.0-0042837972 10.1034/j.1600-0749.2003.00073.x (Pubitemid 37093034)
49. Lin J. Y., Fisher D. E., Melanocyte biology and skin pigmentation. Nature 2007 445 7130 843 850 2-s2.0-33847188116 10.1038/nature05660
50. Lin J., Takata M., Murata H., Goto Y., Kido K., Ferrone S., Saida T., Polyclonality of braf mutations in acquired melanocytic nevi. Journal of the National Cancer Institute 2009 101 20 1423 1427 2-s2.0-70350518191 10.1093/jnci/djp309
51. Van Raamsdonk C. D., Fitch K. R., Fuchs H., De Angelis M. H., Barsh G. S., Effects of G-protein mutations on skin color. Nature Genetics 2004 36 9 961 968 2-s2.0-4444258913 10.1038/ng1412 (Pubitemid 39167492)
52. Onken M. D., Worley L. A., Long M. D., Duan S., Council M. L., Bowcock A. M., Harbour J. W., Oncogenic mutations in GNAQ occur early in uveal melanoma. Investigative Ophthalmology and Visual Science 2008 49 12 5230 5234 2-s2.0-58149216961 10.1167/iovs.08-2145
53. Lamba S., Felicioni L., Buttitta F., Bleeker F. E., Malatesta S., Corbo V., Scarpa A., Rodolfo M., Knowles M., Frattini M., Marchetti A., Bardelli A., Mutational profile of GNAQ in human tumors. PLoS One 2009 4 8 2-s2.0-69949119638 10.1371/journal.pone.0006833 e6833
54. Bauer J., Kilic E., Vaarwater J., Bastian B. C., Garbe C., De Klein A., Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. British Journal of Cancer 2009 101 5 813 815 2-s2.0-70249134535 10.1038/sj.bjc.6605226
55. Chang F., Steelman L. S., Shelton J. G., Lee J. T., Navolanic P. M., Blalock W. L., Franklin R., McCubrey J. A., Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). International journal of oncology 2003 22 3 469 480 2-s2.0-0037806885
56. Medrano E. E., Yang F., Boissy R., Farooqui J., Shah V., Matsumoto K., Nordlund J. J., Park H. Y., Terminal differentiation and senescence in the human melanocyte: repression of tyrosine-phosphorylation of the extracellular signal-regulated kinase 2 selectively defines the two phenotypes. Molecular Biology of the Cell 1994 5 4 497 509 2-s2.0-0028306229 (Pubitemid 24178327)
57. Wellbrock C., Rana S., Paterson H., Pickersgill H., Brummelkamp T., Marais R., Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS One 2008 3 7 2-s2.0-50549104987 10.1371/journal.pone. 0002734 e2734
58. Voice J. K., Klemke R. L., Le A., Jackson J. H., Four human Ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. Journal of Biological Chemistry 1999 274 24 17164 17170 2-s2.0-0033546419 10.1074/jbc.274.24.17164 (Pubitemid 29275179)